Tacrolimus eye drops as monotherapy for vernal keratoconjunctivitis: a randomized controlled trial

Müller, Eduardo Gayger; Santos, Myrna Serapião dos; Freitas, Denise; Gomes, José Álvaro Pereira; Belfort Jr, Rubens.
Arq. bras. oftalmol ; 80(3): 154-158, May-June 2017. tab, graf
Artículo en Inglés | LILACS | ID: biblio-888114

Documentos relacionados

  1. Epithelial barrier dysfunction in ocular allergy.
  2. Clinical characteristics and outcomes of ocular allergy in Thai children.
  3. Evaluation of corneal epithelial thickness mapping using anterior segment OCT in children with vernal keratoconjunctivitis.
  4. Correlation between gene expression and clinical scores in vernal keratoconjunctivitis.
  5. Topical cyclosporine versus allergen specific immunotherapy in perennial allergic conjunctivitis.
  6. Severe allergic eye disease: What to do and when?
  7. A comparative study between ciclosporine A eye drop (2%) and tacrolimus eye ointment (0.03%) in management of children with refractory vernal keratoconjunctivitis.
  8. When to start tacrolimus ointment for vernal keratoconjunctivitis? A proposed treatment protocol.
  9. Tear N-glycomics in vernal and atopic keratoconjunctivitis.
  10. Corneal biomechanical properties in vernal keratoconjunctivitis and its subtypes: a preliminary study.